Incretin-based drugs and intestinal obstruction: a pharmacovigilance study
In fact, manufacturers of marketed, weekly injectable GLP-1 products recommend that a patient consider reinitiating GLP-1 therapy at the initial starting dose if two doses or more are missed, to avoid tolerability issues associated with rapid increases in GLP-1 exposure levels
Healing also depends on collagen remodeling, fibroblast activity, vascular signaling, inflammation control, progressive loading, adequate protein intake, sleep, and correction of the movement pattern that caused the injury
Lena wound up switching to Novo Nordisk's Wegovy, CVS Caremark's preferred obesity drug, and was relieved that it worked for her